January 20th, 2021
Reify Health Announces Global Expansion of StudyTeam to Over 2,700 Clinical Research Sites
Patient Enrollment Performance Management platform now available in over 100 countries
BOSTON, January 20, 2021 – Reify Health, provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced that StudyTeam is now available to clinical research sites in 100 countries worldwide. In the last year alone, Reify Health has expanded availability of StudyTeam to 88 new countries. This milestone marks Reify Health’s investment in providing sites with effective solutions to manage recruitment and enrollment and drastically reduce the manual work historically required from sites during trials.
“Once a protocol has been designed, research sites do the lion’s share of the work to bring a clinical trial to life,” said Ralph Passarella CEO and co-founder of Reify Health. “Unfortunately, our industry has underinvested in solutions that help site staff do their job more efficiently and effectively. Developing solutions that empower research site staff to recruit and enroll patients more efficiently has been a large part of our mission for years. We’ve worked tirelessly to build useful technology and make it available to all research sites around the globe. We are proud to have reached this milestone on our journey, and we are committed to continuing our work to support each research coordinator in every country where clinical trials are run.”
Clinical research sites typically spend countless hours managing recruitment and enrollment and duplicating work manually. StudyTeam solves this problem by giving sites a centralized platform to manage patients across all trials and sponsors. Additionally, the platform connects directly with research sponsors so that critical enrollment information can be communicated securely and in real time. Sites using StudyTeam enroll over 15 percent more patients per month compared to sites that don’t use StudyTeam. Additionally, sites using StudyTeam have also reported a substantial decrease in the time clinical research coordinators spend managing recruitment and enrollment for sponsor trials.
Currently, more than 2,700 global research sites use StudyTeam to manage patient recruitment and enrollment. Those sites are connected seamlessly and securely with numerous leading biopharma sponsors – including Amgen, AstraZeneca, and Eli Lilly and Company – so that critical information about recruitment activity can be shared in real time without sites needing to duplicate work they have already done.
“StudyTeam has been a game-changer for our site network. It takes hours-long processes that our coordinators were required to do by the sponsors and compresses them to minutes – giving us more time to work with and educate patients. StudyTeam also helps us recruit and enroll qualified patients more effectively. Our entire team can work together seamlessly in the system increasing our capacity to enroll the right patients in the right trials quickly.” — Rebecca Goldfaden, vice president of clinical operations at East Coast Institute for Research
Additional benefits reported by sites using StudyTeam include:
• A simple user experience that’s built around site workflows. StudyTeam for Sites was developed based on thousands of hours of research with site staff and designed by current and former Research Coordinators at sites. Reify Health did this to ensure StudyTeam fits into how sites work as opposed to giving sites one more place to go to track their work.
•A single, centralized portal for recruitment, pre-screening, and enrollment activities. Sites spend countless hours managing patient recruitment work in separate sponsor-backed solutions. They are then forced to duplicate these efforts for each sponsor with which they work. StudyTeam gives sites a centralized place to do this across all trials and sponsors.
• A more secure way to share information with sponsors. Patient privacy is of paramount importance to all sites. StudyTeam has built in features to virtually eliminate the possibility of inappropriately sharing patient health information with sponsors.
• Zero cost to sites. StudyTeam is completely free for sites.
About Reify Health
Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. Reify serves the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world's largest biopharmaceutical companies. The global healthcare system relies on clinical trials to develop new, life-saving treatments for patients. Reify Health’s StudyTeam software empowers both the research sponsors who drive clinical trials forward and the doctors and research coordinators who care for patient volunteers so that they can devote more focus and time toward the work that results in successful clinical research. To learn more, visit www.reifyhealth.com.
Reify Health Powers Patient Recruitment and Enrollment Across AstraZeneca’s Extensive Breast Cancer Clinical Trial Pipeline
AstraZeneca will use Reify Health’s StudyTeam™ platform to accelerate ...Read More
The two fast-growing organizations will combine innovative software ...Read More